EU Scrutinizes J&J, Novartis Generic Painkiller Deals

Law360, New York (October 21, 2011, 2:27 PM EDT) -- The European Commission has begun examining whether agreements between Johnson & Johnson and Novartis AG's generics units have kept cheaper versions of a powerful painkiller off the Dutch market, the antitrust watchdog said Friday.

The probe focuses on Fentanyl, which is used to treat moderate or severe chronic pain for those who have become tolerant to other pain medications. The regulator is investigating whether agreements between the U.S.-based J&J and Switzerland's Novartis have or were designed to delay generic versions of the treatment from entering the...
To view the full article, register now.